ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Primates"

  • 2016 American Transplant Congress

    Acute Rejection in Non-Human Primates Treated with Belatacept Is Mediated by a Unique CD8 Memory Subset.

    D. Mathews,1 W. Wakwe,1 M. Lowe,1 C. Breeden,1 F. Leopardi,1 A. Farris,1 M. Song,1 E. Strobert,2 J. Jenkins,2 C. Larsen,1 R. Townsend,3 A. Adams.1

    1Emory Transplant Center, Emory University, Atlanta, GA; 2Yerkes National Primate Research Center, Atlanta, GA; 3Bristol Myers-Squibb Pharmaceutical Research Institute, Princeton, NJ.

    Belatacept is a high affinity version of the fusion protein CTLA4-Ig that blocks CD28 mediated T cell costimulation, providing a more targeted/less toxic form of…
  • 2016 American Transplant Congress

    Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

    M. Ezzelarab,1 H. Zhang,1 L. Lu,1 H. Guo,1 A. Zahorchak,1 R. Wiseman,2 M. Nalesnik,3 J. Bhama,1 D. Cooper,1 A. Thomson.1,4

    1Surgery, University of Pittsburgh, Starzl Institute, Pittsburgh, PA; 2Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI; 3Pathology, University of Pittsburgh, Pittsburgh, PA; 4Immunology, University of Pittsburgh, Pittsburgh, PA.

    Background:The ability of regulatory T cells (Treg) to prolong allograft survival and promote transplant tolerance in lymphodepleted rodents is well-established. Few studies have addressed the…
  • 2016 American Transplant Congress

    Limited Efficacy of Bortezomib on Desensitization via Rapid Humoral Compensation in a Sensitized Rhesus Model.

    J. Kwun,1 C. Burghuber,1 N. Iwakoshi,2 A. Gibby,2 S. Knechtle.1

    1Surgery, Duke University, Durham; 2Surgery, Emory University, Atlanta.

    Sensitized patients comprise a significant proportion (30%) of candidates on the waiting list for transplantation. With recent evidence that the presence of donor-specific antibodies (DSA)…
  • 2016 American Transplant Congress

    Late Renal Xenograft Failure Is Antibody-Mediated: Description of the Longest-Reported Survival in Pig-to-Primate Renal Xenotransplantation.

    L. Higginbotham,1 S. Kim,1 D. Mathews,1 A. Stephenson,1 C. Breeden,1 C. Larsen,1 M. Ford,1 K. Newell,1 A. Tector,2 A. Adams.1

    1Emory Transplant Center, Emory University Hospital, Atlanta, GA; 2Indiana University School of Medicine, Indianapolis, IN.

    Introduction. Xenotransplantation has the potential to alleviate the organ supply shortage, yet pig-to-primate renal xenotransplant has met limited success due to natural preformed anti-pig antibody.…
  • 2016 American Transplant Congress

    Utilizing HLA Single Antigen Flow Beads Assays to Evaluate Anti-MAMU Antibody in Sensitized Nonhuman Primate Model.

    J. Kwun,1 C. Burghuber,2 M. Manook,1 A. Clark,3 D. Chen,3 S. Knechtle.1

    1Surgery, Duke University, Durham; 2Surgery, Medical University of Vienna, Vienna, Austria; 3Pathology, Duke University, Durham.

    [Background] Non-human primate models of sensitization provide great preclinical models to investigate the mechanisms of antibody-mediated rejection or desensitization. Now there a growing interest on…
  • 2016 American Transplant Congress

    CXCL12 as Innovative Immune Isolating Chemokine for Microencapsulated Allo and Xeno-Transplantation in NHPs.

    M. Sremac,1 A. Saraya,1 O. Clemente,1 M. Penson,1 S. Chavan,3 N. Chronos,3 C. Schuetz,2 J. Lei,2 J. Markmann,2 T. Brauns,1 M. Poznansky.1

    1Infectious Disease/VIC, Massachusetts General Hospital, Boston, MA; 2Division of Transplantation, Massachusetts General Hospital, Boston, MA; 3VICapsys, Inc, Athens, GA.

    Introduction The purpose of this study is to determine whether a clinical-grade alginate-microencapsulant incorporating CXCL12, can protect and sustain the function of allo and/or adult…
  • 2016 American Transplant Congress

    Radiosensitive Cell Population Prolongs Graft Survival of Vascularized Composite Allografts in Non-Human Primates.

    M. Uluer, J. Woodall, W. Hassanein, U. Drhu, B. Bojovic, A. Nam, S. Bartlett, R. Barth.

    University of Maryland School of Medicine, Baltimore, MD.

    Background: Vascularized composite allografts (VCA) containing vascularized bone marrow (VBM) prolong graft survival. To help elucidate this protective immunomodulatory effect, we irradiated donor facial VCA…
  • 2016 American Transplant Congress

    Skin as a Harbinger of Rejection of Underlying Structures in Vascularized Composite Allografts: Concordance or Discordance?

    L. Cendales,1 M. Levine,2 S. Bartlett,3 J. Cheeseman,1 C. Drachenberg,3 W. Hancock,4 M. Joshi,1 A. Kirk,1 F. Leoopardi,1 S. Levin,2 M. Uluer,3 A. Selim,5 M. Song,1 W. Twaddell,3 L. Wang,4 Z. Wang,2 R. Barth.3

    1Surgery, Duke University, Durham, NC; 2University of Pennsylvania, Philadelphia, PA; 3University of Maryland School of Medicine, Baltimore, MD; 4Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; 5Pathology, Duke University, Durham, NC.

    Vascularized composite allografts (VCA) are composed of multiple tissue types. It has not been determined as to whether there is an immune hierarchy or differential…
  • 2016 American Transplant Congress

    Belatacept Immunotherapy Is Not Augmented by Blockade of Activated LFA-1 in a Nonhuman Primate Renal Transplant Model.

    K. Samy,1 M. Mulvihill,1 B. Collins,1 D. Lo,2 M. Song,1 F. Leopardi,1 A. Kirk.1,2

    1Department of Surgery, Duke University Medical Center, Durham, NC; 2Emory University, Atlanta, GA.

    Purpose: Belatacept specifically targets de novo alloimmune responses without off target side effects. However, resistant alloreactive memory T cells have complicated its use. LFA-1 therapy…
  • 2015 American Transplant Congress

    Anti-CD122 + Costimulation Blockade Prolongs Allograft Survival

    D. Mathews,1 L. Higginbotham,1 Y. Dong,1 C. Breeden,1 C. Larsen,1 J. Tso,2 A. Adams.1

    1Emory Transplant Center, Emory University, Atlanta, GA; 2JN Bioscience, Mountanview, CA.

    Introduction: Effective T cell activation and effector function requires (1) cognate antigen recognition (2) appropriate costimulation and (3) successful cytokine signaling. Recently approved strategies to…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences